Logo-brb

Biomedical Research Bulletin
Original Article

1. Investigation of Biochemical Factors in Multiple Sclerosis Patients With Fingolimod and Natalizumab Drugs
Mobina Belalzadeh, Farshad Anguti, Samira Vedadi, Mina Deljavan Ghodrati* ORCID
Biomed Res Bull. 2023;1(1): 7-10. doi: 10.34172/biomedrb.2023.03
Article
PDF
Full Text
XML
Cited By:
0
CitedBy Google Scholar 0
Original Article

2. Sericin Has the Same Function With Natalizumab by Decreasing RORɤT and CD4 in a Multiple Sclerosis Animal Model
Zahra Sheikhalizadeh* ORCID, Ghazal Majidi, Zahra Hakimzadeh, Misagh Majidi
Biomed Res Bull. 2024;2(3): 118-123. doi: 10.34172/biomedrb.2024.18
Article
PDF
XML
Cited By:
0